Skip to content

FARMAFENDER: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FARMAFENDER

BE 0819.991.676
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€70,343
2024 · €46,039+€24,303
Equity
€169,514
2024 · €138,199+€31,315
Cash
€16,186
2024 · €10,385+€5,801
Balance sheet total
€269,880
2024 · €193,680+€76,200

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€98,695

    up €98,695 (+122%), from €80,909 to €179,605

    of which Other amounts receivable: +€94,410

  • Current investments -€27,867

    down €27,867 (-35.4%), from €78,677 to €50,810

  • Cash +€5,801

    up €5,801 (+55.9%), from €10,385 to €16,186

    mainly Net result for the year (+€70,343) and Other debts (+€39,027)

Equity and liabilities
  • Other debts +€39,027

    new in 2025: €39,027

  • Reserves +€31,315

    up €31,315 (+23.7%), from €131,999 to €163,314

    of which Distributable reserves: +€33,175

  • Tax, wage and social debts +€3,357

    up €3,357 (+7.0%), from €47,980 to €51,337

  • Trade debts +€3,154

    up €3,154 (+46.0%), from €6,848 to €10,002

Income statement
  • Gross operating margin +€18,308

    up €18,308 (+23.8%), from €76,818 to €95,126

  • Financial income +€6,830

    up €6,830 (+205%), from €3,338 to €10,168

  • Taxes +€1,455

    up €1,455 (+5.3%), from €27,432 to €28,887

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €46,039
Gross operating margin +€18,308
Depreciation -€73
Other operating charges +€93
Financial income +€6,830
Financial charges +€600
Taxes -€1,455
Result 2025 €70,343
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€18,538
Investment +€26,291
Financing -€39,027
Cash 2024 €10,385
Net result for the year +€70,343
Depreciation +€3,666
Receivables within one year -€98,695
Deferred charges and accrued income -€1,660
Trade debts +€3,154
Tax, wage and social debts +€3,357
Other debts +€39,027
Accrued charges and deferred income -€653
Investment in fixed assets (net) -€1,576
Current investments +€27,867
Contributions, distributions and other -€39,027
Cash 2025 €16,186
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €193,680 €269,880 +€76,200 +39.3%
Fixed assets 21/28 €17,838 €15,749 -€2,090 -11.7%
Tangible fixed assets 22/27 €17,763 €15,674 -€2,090 -11.8%
Plant, machinery and equipment 23 €3,642 €3,132 -€510 -14.0%
Furniture and vehicles 24 €5,661 €5,059 -€602 -10.6%
Other tangible fixed assets 26 €8,460 €7,482 -€978 -11.6%
Financial fixed assets 28 €75 €75 = 0.0%
Current assets 29/58 €175,842 €254,132 +€78,289 +44.5%
Amounts receivable within one year 40/41 €80,909 €179,605 +€98,695 +122%
Trade receivables 40 €27,071 €31,356 +€4,285 +15.8%
Other amounts receivable 41 €53,838 €148,249 +€94,410 +175%
Current investments 50/53 €78,677 €50,810 -€27,867 -35.4%
Cash at bank and in hand 54/58 €10,385 €16,186 +€5,801 +55.9%
Deferred charges and accrued income 490/1 €5,872 €7,531 +€1,660 +28.3%
Total equity and liabilities 10/49 €193,680 €269,880 +€76,200 +39.3%
Equity 10/15 €138,199 €169,514 +€31,315 +22.7%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €131,999 €163,314 +€31,315 +23.7%
Non-distributable reserves 130/1 €1,860 €0 -€1,860 -100%
Reserves not available under the articles 1311 €1,860 €0 -€1,860 -100%
Distributable reserves 133 €130,139 €163,314 +€33,175 +25.5%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €55,482 €100,366 +€44,885 +80.9%
Amounts payable within one year 42/48 €54,828 €100,366 +€45,538 +83.1%
Trade debts 44 €6,848 €10,002 +€3,154 +46.0%
Suppliers 440/4 €6,848 €10,002 +€3,154 +46.0%
Taxes, remuneration and social security 45 €47,980 €51,337 +€3,357 +7.0%
Taxes 450/3 €47,980 €51,337 +€3,357 +7.0%
Other amounts payable 47/48 - €39,027 +€39,027
Accrued charges and deferred income 492/3 €653 €0 -€653 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,593 €3,666 +€73 +2.0%
Other operating charges 640/8 €816 €723 -€93 -11.4%
Gross operating margin 9900 €76,818 €95,126 +€18,308 +23.8%
Operating profit (loss) 9901 €72,409 €90,737 +€18,328 +25.3%
Financial income 75/76B €3,338 €10,168 +€6,830 +205%
Recurring financial income 75 €3,338 €10,168 +€6,830 +205%
Financial charges 65/66B €2,276 €1,676 -€600 -26.4%
Recurring financial charges 65 €2,276 €1,676 -€600 -26.4%
Profit (loss) for the period before taxes 9903 €73,471 €99,229 +€25,758 +35.1%
Income taxes 67/77 €27,432 €28,887 +€1,455 +5.3%
Profit (loss) for the period 9904 €46,039 €70,343 +€24,303 +52.8%
Profit (loss) for the period to be appropriated 9905 €46,039 €70,343 +€24,303 +52.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.